PacificHealth Laboratories Announces Private Sale of Convertible Preferred Stock and Termination of SEC Reporting Requirements
April 01 2013 - 9:00AM
Marketwired
PacificHealth Laboratories, Inc. (OTCQB: PHLI), a nutrition
technology company, announced today the completion of a private
placement of Convertible Preferred Stock resulting in net proceeds
to the Company of $866,390. The Company will also voluntarily
deregister its common stock under the Securities Exchange Act of
1934 and will no longer be subject to SEC reporting requirements.
President and CEO Fred Duffner along with all the directors
participated in the private placement. There were no fees or
expenses associated with this placement. The Preferred Stock is
convertible into common stock of PHLI at $0.07 per share, carries
an 8% cumulative dividend, and includes common stock warrant
coverage of 50% of capital invested with an exercise price of $0.10
per common share.
Fred Duffner, CEO and President of PacificHealth Laboratories,
said, "During the past two years we have invested our resources
against growing our core endurance business. Although it has
stabilized, we have not seen the growth that was expected and it
came at higher costs. Last year we were also able to secure the
licensing agreement to market BODY GLOVE SURGE™ which we launched
in an 'All Natural' Gel format in late 2012. We have plans during
the second quarter this year to launch BODY GLOVE SURGE 'All
Natural' Energy Shot. The Board has approved a strategy of reducing
costs and investments against our core business and reallocating
our investments in support of BODY GLOVE SURGE Energy Shots. As
part of the cost reduction the Board has also approved termination
of our SEC reporting requirements and will cease all SEC reporting.
This will allow additional savings from accounting and filing
fees."
About PacificHealth: PacificHealth
Laboratories, Inc. (OTCQB: PHLI), founded in 1996 by two prominent
scientists, started with a singular purpose -- to help athletes
achieve their personal goals. We never lost sight of that mission.
Collaborating with some of the world's top nutritionists,
biochemists and sports scientists, our research and products have
reshaped sports nutrition. Our discoveries help muscles work
stronger, faster and longer and are an integral part of the daily
training and race regimens of athletes at all levels. However, we
are most proud of the simple fact that our products "power your
passion." To learn more, visit www.pacifichealthlabs.com.
Notice: This news release and oral statements made from time to
time by Company representatives concerning the same subject matter
may contain so-called "forward-looking statements." These
statements can be identified by introductory words such as
"expects," "plans," "will," "estimates," "forecasts," "projects,"
or words of similar meaning and by the fact they do not relate
strictly to historical or current facts. Forward-looking statements
frequently are used in discussing new products and their potential.
Many factors may cause actual results to differ from
forward-looking statements, including inaccurate assumptions and a
broad variety of risks and uncertainties, some of which are known,
such as general economic conditions, consumer product acceptance
and competitive products, and others of which are not. No
forward-looking statements are a guarantee of future results or
events, and one should avoid placing undue reliance on such
statements.
Contact: Stephen Kuchen 732-739-2900, x603 Email Contact
PacificHealth Laboratories (CE) (USOTC:PHLI)
Historical Stock Chart
From Jan 2025 to Feb 2025
PacificHealth Laboratories (CE) (USOTC:PHLI)
Historical Stock Chart
From Feb 2024 to Feb 2025